1443MO Differences in hematologists’ and palliative care physicians’ recommended indications and opinions on transfusion therapy for patients with hematological malignancy post-anticancer therapy

Abstract

Transfusion therapy occasionally impedes the transition of patients with hematological malignancies to specialized palliative care. This study investigated differences in the opinions of hematologists (HOs) and palliative care physicians (PCs) regarding indications for end-of-life transfusion therapy.